Cervical Cancer Market
Cervical cancer occurs in the cells of the cervix&mdash;the lower part of the uterus that connects to the vagina. It usually originates in the cervix's transformation zone and spreads to regional lymph nodes; parametrial invasion is also common. The most significant cause of cervical cancer is persistent papillomavirus infection. HPV is detected in ~90% of cervical tumors, particularly the oncogenic subtypes such as HPV 16 and 18.&nbsp;
&nbsp;
Types of Cervical Cancer
<ul>
<li>Squamous cell carcinoma</li>
<li>Adenocarcinoma</li>
</ul>
&nbsp;
Cervical Cancer Epidemiology Insights (2022)
<ul>
<li>Approximately 90% of cervical cancers occur in low-income and middle-income countries that lack organized screening and HPV vaccination programs</li>
<li>Cervical cancer is most often diagnosed between the ages of 35 and 44</li>
<li>Over 20% of cervical cancers are diagnosed after age 65</li>
</ul>
&nbsp;
Current Cervical Cancer Treatment Options
<ul>
<li>AVASTIN</li>
<li>Cisplatin</li>
<li>TIVDAK</li>
<li>KEYTRUDA</li>
</ul>
&nbsp;
Cervical Cancer Market Strengths
<ul>
<li>Increase in the incidence of oncological disease</li>
</ul>
&nbsp;
Cervical Cancer Market Opportunities
<ul>
<li>A large number of ongoing clinical trials</li>
</ul>
&nbsp;
Cervical Cancer Emerging Drugs
<ul>
<li>Tiragolumab: Hoffmann la Roche</li>
<li>LN-145: Iovance Biotherapeutics, and others</li>
</ul>

Cervical Cancer Market 

Cervical Cancer Infographics

Cervical Cancer Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.